Hemas
HHL.N0000Capital GoodsMain Board
Rs31.20
+0.40 (+1.30%)Market closedPrices for November 4Delayed up to 15 minutesPrices are polled from the exchange every 15 minutes during the session, so what you see can be up to 15 minutes old. Not suitable for trading decisions on the minute.
52-week low
27.60
52-week high
36.70
- Previous closeThe level at the end of the previous trading day — the baseline today's change is measured from.
- 30.80
- Open
- 31.00
- Day rangeThe lowest and highest level reached during today's session; the marker shows where it stands now.
- 30.90 – 31.30
- Shares tradedHow many shares changed hands. Compare it with the usual volume: a move on heavy volume has more participants behind it.
- 126.9K
- 0.5× the 30-day average
- TurnoverThe rupee value of every share that changed hands today (price × shares, summed). Higher turnover means more money moved through the market.
- Rs 3.9M
- 117 trades
- Market valueMarket capitalisation: share price × shares issued. For the market, the total value of every listed company at today's prices.
- Rs 93.5B
- 1.26% of the whole market
- Since 1 JanuaryYear to date: the change since the last close of the previous year.
- −10.09%
- Dividend yield
- 3.21%
- BetaHow much the share has tended to move when the market moves. 1 means in step with the ASPI; above 1, more than the market; below 1, less.
- 1.12
- Foreign holding
- —
Price history
Full chart with events2026-11-04O 31.00H 31.30L 30.90C 31.20+1.30%Vol 126.9K
Blue dots mark days the company was in the news. Point at one to read the headline.
In plain words
What the chart above shows, measured. Not advice.
- The price is above its 50-day average (Rs 30.87) but below its 200-day average (Rs 31.87): better than recent months, still below the year's average.
- Momentum (RSI) is 58, between the 30 and 70 that chart readers watch: neither a fast rise nor a fast fall.
- A quiet day: 0.5× its usual daily volume.
- −0.64% over the last month, −1.27% over the last three.
If you had invested
Rs 9,174−Rs 826 (−8.26%)
- Bought on Nov 4, 2025
- 285 shares at Rs 35.10
- Worth today
- Rs 8,889
- Dividends received
- Rs 285
Before brokerage and tax, counting part shares. Past prices do not tell you future ones.
Hemas in the news
Articles where the company or its directors are the subject, with the line that names it.
India, Qatar among 7 countries in race to host 2036 Olympics
The purchase is made through Hemas Holdings’ subsidiary Atlas Axillia.
DealsNewsWire EnglishHow Hemas’ US$16.2 million went to Kenya
Hemas Holdings PLC, one of Sri Lanka's leading diversified business groups, has acquired a 75% stake in Twiga Stationers & Printers Limited, one of Kenya's leading stationery manufacturers, for US$16.2 million through its wholly owned subsi…
Sri Lanka MirrorHemas eyes Africa expansion through Kenya acquisition
Sri Lanka's Hemas Holdings PLC is considering its recent 75% acquisition of Kenya's leading stationery company, Twiga, as its main entry point into the African market, Group CEO Ashish Chandra...
DealsSunday ObserverHemas makes first overseas acquisition with $16.2m Kenya deal
Hemas Holdings PLC announced its first international acquisition by investing USD 16.2 million for a 75% majority stake in Kenyan statio Hemas Holdings PLC announced its first international acquisition by investing USD 16.2 million for a 75…
DealsHiru News - EnglishHemas Holdings profit up 18-pct in March 2026 quarter, healthcare up 9-pct
…ith passenger volumes in the aviation segment affected ECONOMYNEXT - Profits at Hemas Holdings PLC, a diversified Sri Lankan conglomerate, rose 17.6 percent to 3.03 billion rupees for the March 2026 quarter, the interim financial report sho…
ResultsEconomyNextHemas Holdings Marks a Milestone Year: FY26 Delivers the Strongest Earnings for the Group
Hemas Holdings PLC announced record earnings for both the fourth quarter (Q4) and full financial year FY26, marking a historic milestone for the Group.
ResultsAda Derana BizHemas Posts Resilient Nine-Month Results Led by Healthcare Sector
Hemas Holdings PLC reported resilient financial performance for the nine months ended 31 December 2025, supported by strong growth in its Healthcare and Mobility sectors, despite temporary disruptions from Cyclone Ditwah and selective macro…
ResultsAda Derana BizSri Lanka’s Hemas Group Dec 2025 quarter profit down 12.8-pct
…impact on business ecosystem in affected area: Hemas ECONOMYNEXT - Sri Lanka's Hemas Holdings said December 2025 quarter group net profit was down 12.8 to Rs.2.6 billion compared with a year ago with high cost and impact of Cyclone Ditwah…
ResultsEconomyNext
In market reports
Where the day's market wrap named this share.
Connections
Who Hemas is linked to — by the news, its directors, its group and its sector.
- In the news together
- Sector peers
In the news together
- COMB Commercial Bank+1.77%
1 article about both · “Hatton National Bank Wins Best Corporate Citizen Sustainability Award 2025”
- HNB HNB+1.92%
1 article about both · “Hatton National Bank Wins Best Corporate Citizen Sustainability Award 2025”
Sector peers
- JKH John Keells Holdings+2.25%
- HAYL Hayleys+0.91%
- ACL ACL Cables PLC+2.11%
- RICH Richard Pieris+0.37%
- SPEN Aitken Spence PLC+1.34%
Board of directors
The directors on the company's board today.
A. Fernando
ChairmanIndependent
A. Chandra
Chief Executive OfficerExecutive
M.A.H. Esufally
Deputy ChairmanNon-executive
S. Esufally
Executive
A.N. Esufally
Non-executive
I.A.H. Esufally
Non-executive
R. P. Pathirana
Independent
T. Perera
Independent
S. Weerasinghe
Independent
Board changes
From the company's own notices, newest first.
- Ms. Sabrina Esufally · Appointed to the boardJuly 1, 2026
- Mr. Ajith Fernando · Became chairpersonJanuary 1, 2026
- Mr. Husein Esufally · Retired from the boardDecember 2, 2025
Dividends
3.21% yield over the last 12 months at today's price.
| Per share | Ex-dividend | Payment | Type |
|---|---|---|---|
| Rs 0.75 | Jun 30, 2026 | Jul 17, 2026 | Final · Financial year ended 31.03.2026 |
| Rs 0.25 | Nov 18, 2025 | Dec 5, 2025 | Interim · Year ending 31st March 2026 |
Disclosures
Corporate disclosure
Appointment of directors
Appointment of Ms. Sabrina Esufally as an Executive Director w.e.f.1st July 2026
Dealings by directors
Mr. Ranil Pathirana, Independent Non-Executive Director is also a director of Rosewood (Pvt) Ltd.
Extraordinary general meeting
Annual general meeting - approved
Extraordinary general meeting (initial)
Circular to shareholders
Employee share option schemes (ESOS) - initial
Cash dividend
A final dividend of Rs.0.75 per share for the financial year ended 31.03.2026
Rs 0.75 a shareEx-dividend Jun 30, 2026Paid Jul 17, 2026Filing (PDF)
Corporate disclosure
Directors' dealings
Directors buying and selling their own companies' shares.
About the company
In the company's own words.
Conglomerate with focused interest in Consumer and Healthcare.
- Established
- 1948
- Listed
- October 15, 2003
- ISIN
- LK0337N00002
- Shares issued
- 2,995,985,015
- All-time rangePrices as they were traded. A share split or bonus issue makes old prices look much higher than today's without anyone losing money.
- 19.10 – 198.00
- Company secretaries
- Hemas Corporate Services (Private) Limited, "Hemas House" No. 75, Braybrooke Place, Colombo 02
- Auditors
- Ernst & Young
Company names, announcements and descriptions are shown in English, in the companies' own words.
Prices are delayed by up to 15 minutes. This page is information to help you look, not investment advice: check a company's own announcements and speak to a licensed stockbroker or adviser before you buy or sell.